Ubiquiti Networks, Inc. — FY2017 Form 10-K
Reporting period: Fiscal year ended June 30, 2017; the filing also reports fourth-quarter results. Although the request metadata says “2016 Q4,” this 10-K covers FY2017 and its fourth quarter ended June 30, 2017. Amounts below are U.S. dollars.
Business context
Ubiquiti develops networking products for service providers, enterprises and consumers. It sells mainly through distributors and online retailers, relying on a global user community for product feedback, awareness and support rather than a traditional direct sales force. The company reported more than 70 million devices sold across over 200 countries and territories. Enterprise products, including UniFi, and service-provider products are its main revenue categories; AmpliFi marked an expansion into consumer Wi-Fi.
Key financial results
| Metric | FY2017 | FY2016 | Change |
|---|---|---|---|
| Revenue | $865.3 million | $666.4 million | +30% |
| Gross profit / gross margin | $395.7 million / 45.7% | $324.8 million / 48.7% | Margin down about 3 points |
| Operating income / margin | $289.8 million / 33.5% | $242.1 million / 36.3% | Income +20% |
| Net income / net margin | $257.5 million / 29.8% | $213.6 million / 32.1% | Income +21% |
| Diluted EPS | $3.09 | $2.49 | +24% |
| Operating cash flow | $112.0 million | $197.5 million | Down $85.5 million |
| Cash and cash equivalents | $604.2 million | $551.0 million | Up $53.2 million |
| Total debt at year-end | $256.6 million | $202.6 million | Up about $54.0 million |
Enterprise Technology revenue rose 65% to $409.7 million and represented 47% of sales, versus 37% in FY2016. Service Provider Technology revenue grew 9% to $455.6 million. Gross margin declined amid a less favorable product mix, higher fulfillment costs, inventory-obsolescence charges and warranty accruals. Operating cash flow was reduced by working-capital investment, particularly a $87.0 million increase in inventory, a $58.2 million increase in receivables and a $22.7 million increase in vendor deposits.
At June 30, 2017, working capital was $853.8 million. Cash exceeded reported debt by approximately $347.6 million, though $546.8 million of cash was held outside the United States. The company said it did not expect to repatriate those funds and that doing so could generate significant tax liabilities. FY2017 investing cash outflow was $7.2 million; financing cash outflow was $51.6 million, including $105.2 million of share repurchases, partly offset by net revolver borrowings.
Fourth-quarter FY2017 revenue was $228.6 million, gross profit $103.2 million, operating income $71.7 million and net income $60.7 million. Compared with Q4 FY2016, revenue rose from $185.7 million and net income from $57.7 million, while gross margin was lower, approximately 45.1% versus 48.4%.
Material changes and notable items
- Revenue growth accelerated to 30% in FY2017 from 12% in FY2016, led by enterprise adoption; enterprise share of revenue increased ten percentage points.
- Operating cash flow fell despite higher earnings, reflecting inventory and other working-capital needs. Inventory increased to $142.0 million from $57.1 million.
- The company repurchased $105.2 million of stock in FY2017 and had $1.3 million remaining under the then-current $50 million program at year-end. It stated it had no plans to pay cash dividends in the foreseeable future.
- The effective tax rate declined to 9.7% from 11.0%, primarily due to a $7.9 million benefit from early adoption of share-based-payment accounting guidance.
- Previously reported material weaknesses in internal controls were reported as remediated as of June 30, 2017; management and the auditor concluded internal control over financial reporting was effective at that date.
Outlook, risks and contingencies
- Outlook: No numerical revenue or earnings guidance is provided. Management expected cash, operating cash generation and facility availability to meet working-capital and capital-expenditure needs for at least the next 12 months. It expected R&D and SG&A spending to increase as the company expands products and operations.
- Credit: The amended facility provides a $100 million term loan and a $300 million revolving facility, maturing March 2020. Revolver availability was $119 million at year-end. Covenants include maximum leverage of 2.50:1 and minimum liquidity of $250 million. Floating-rate debt exposes earnings to rate increases.
- Concentration and supply: One customer represented 11% of FY2017 revenue; sales to distributors were 99% of revenue. The company depends on contract manufacturers, primarily in China, and limited or single sources for certain components, including Qualcomm Atheros chipsets and related technology licensing.
- Fraud recovery: A 2015 business-email-compromise fraud transferred $46.7 million. The company had recovered $16.7 million in total by FY2016, with no further recovery in FY2017, and continued to pursue the remaining $30.0 million. Further recovery was described as remote and uncertain.
- Litigation: A shareholder class-action settlement of $6.8 million was filed in August 2017, subject to court approval, and expected to be funded largely by insurers. Synopsys and Vivato patent-related cases remained active; the company could not estimate possible losses and said it would defend itself.
- Other exposures: Unrecognized tax benefits were $27.4 million, plus $2.4 million of accrued interest. The company also cited cybersecurity, product defects, competitive and demand volatility, foreign exchange, trade and regulatory changes, and dependence on its community-led business model as material risks.
- Related party: The company incurred approximately $2.12 million in FY2017 aircraft-lease expenses under an agreement with an entity owned by CEO Robert Pera.
Most important facts for investors to verify
- Whether enterprise growth and the newer consumer offering can continue, and whether gross margins stabilize after FY2017’s decline.
- Whether inventory, receivables and vendor deposits convert to cash without material write-downs or collection issues.
- Cash accessibility and potential tax costs given the substantial overseas cash balance and indefinite-reinvestment assertion.
- Debt covenant headroom, floating-rate exposure, and the company’s capacity to fund repurchases while maintaining liquidity.
- Customer and component-supplier concentration, and any developments in the Qualcomm Atheros supply and license arrangements.
- Final approval and insurance funding of the shareholder settlement, outcomes of the Synopsys and Vivato litigation, and any recovery of the remaining fraud loss.
- Sustained effectiveness of remediated financial controls and the treatment of related-party aircraft-lease costs.